(lp0
S'BIO-TECHNE Corp  Lowered to Neutral at Janney Montgomery Scott Chaffey Breeze - 15 hours ago Janney Montgomery Scott downgraded shares of BIO-TECHNE Corp  from a buy rating to a neutral rating in a research note issued to investors on Monday morning.Latest Stocks: The Janney Montgomery Scott Downgrades BIO-TECHNE Corp (TECH ... - Petro Global News 24Brokerages Set BIO-TECHNE Corp  Price Target at $117.20 - BNB Daily '
p1
aS'Bio-Techne Corp  Ex-Dividend Date Scheduled for February 15, 2017 Nasdaq - Feb 14, 2017 Bio-Techne Corp  will begin trading ex-dividend on February 15, 2017. A cash dividend payment of $0.32 per share is scheduled to be paid on March 03, 2017.Bio-Techne Corp  to Issue Quarterly Dividend of $0.32 on March 3rd - Sports Perspectives'
p2
aS'BRIEF-Bio-Techne Corp &amp; Bio-Techne has entered into an exclusive license agreement Reuters - Mar 7, 2017 BRIEF-Bio-Techne Corp &amp; Bio-Techne has entered into an exclusive license agreement. March 7 Bio-techne Corp: * Bio-Techne Corp - Bio-Techne has entered into an exclusive license agreement with multiclonal therapeutics. * Bio-Techne Corp - agreement&nbsp;...'
p3
aS'Bio-Techne Corporation Completed its Acquisition of Advanced Cell Diagnostics PR Newswire  - Aug 1, 2016 MINNEAPOLIS, Aug. 1, 2016 /PRNewswire/ -- Bio-Techne Corporation  today announced it has completed its acquisition of Advanced Cell Diagnostics of Newark, CA.'
p4
aS'Checking the Charts on Shares of Bio-Techne Corp  Midway Monitor - 9 hours ago Taking a glance from a technical standpoint, Bio-Techne Corp  presently has a 14-day Commodity Channel Index  of -120.31.'
p5
aS'Bio-Techne Corporation Agrees to Acquire Zephyrus Biosciences, Inc. PR Newswire  - Mar 21, 2016 MINNEAPOLIS, March 21, 2016 /PRNewswire/ -- Bio-Techne Corporation  announced today that it has completed the acquisition of Zephyrus Biosciences.'
p6
aS'Bio-Techne Signs Exclusive License Agreement with Multiclonal Therapeutics for ... PR Newswire  - Mar 7, 2017 Bio-Techne Corporation  is a leading developer and manufacturer of high quality purified proteinsnotably cytokines and growth factors, antibodies, immunoassays, as well as biologically active small molecule compounds --- which are sold&nbsp;...'
p7
aS'Bio-Techne Corp. MarketWatch - Sep 2, 2009 Check out the returns on our 8 Lazy Portfolios that are made up of low-cost buy-and-hold index funds.  How to create your own Lazy Portfolio.'
p8
aS"Bio-Techne Corporation Acquires Access to B-MoGen Biotechnologies' Gene ... PR Newswire  - May 4, 2016 MINNEAPOLIS, May 4, 2016 /PRNewswire/ -- Bio-Techne Corporation  and B-MoGen Biotechnologies, Inc. announced today that Bio-Techne has made a seed investment in B-MoGen and the parties have entered into collaboration&nbsp;..."
p9
aS'Innovative Veterinary Diagnostic Setting A New Standard PR Newswire  - Mar 1, 2017 MINNEAPOLIS, March 1, 2017 /PRNewswire/ -- Bio-Techne Corporation has partnered with Brazil-based DK Diagnostics to release its first diagnostic tool for the veterinary market.'
p10
a.